📰 Nasdaq Prtk News
Nasdaq Prtk News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Prtk. Real-time updates on events, politics, business and more.
October 3, 2023
Perkins Capital Management Inc. lowered its position in shares of Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK – Free Report) by 70.0% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 13,700 shares of the specialty pharmaceutical company’s stock after selling 32,000 shares during the quarter. Perkins […]
September 21, 2023
StockNews.com assumed coverage on shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Free Report) in a research report sent to investors on Monday. The brokerage issued a hold rating on the specialty pharmaceutical company’s stock. Several other equities analysts have also recently weighed in on PRTK. Jefferies Financial Group cut Paratek Pharmaceuticals from a buy rating to […]
September 7, 2023
BOSTON, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (
August 18, 2023
StockNews.com started coverage on shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Free Report) in a research report released on Thursday. The firm issued a hold rating on the specialty pharmaceutical company’s stock. PRTK has been the subject of a number of other reports. HC Wainwright reissued a neutral rating and set a $2.15 price objective on […]
August 18, 2023
StockNews.com assumed coverage on shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Free Report) in a research report sent to investors on Thursday morning. The firm issued a hold rating on the specialty pharmaceutical company’s stock. PRTK has been the subject of several other research reports. HC Wainwright reiterated a neutral rating and issued a $2.15 target […]
July 28, 2023
StockNews.com started coverage on shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Free Report) in a research report report published on Monday morning. The firm issued a hold rating on the specialty pharmaceutical company’s stock. Several other equities analysts also recently commented on PRTK. BTIG Research cut their price target on shares of Paratek Pharmaceuticals from $24.00 […]
July 27, 2023
StockNews.com assumed coverage on shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Get Free Report) in a research report issued to clients and investors on Monday. The brokerage set a “hold” rating on the specialty pharmaceutical company’s stock. Several other equities research analysts have also issued reports on the stock. HC Wainwright lowered shares of Paratek Pharmaceuticals […]
July 19, 2023
StockNews.com started coverage on shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Free Report) in a report issued on Sunday morning. The firm issued a hold rating on the specialty pharmaceutical company’s stock. PRTK has been the subject of several other reports. HC Wainwright downgraded shares of Paratek Pharmaceuticals from a buy rating to a neutral rating […]
July 19, 2023
StockNews.com assumed coverage on shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Free Report) in a research report sent to investors on Sunday morning. The firm issued a hold rating on the specialty pharmaceutical company’s stock. Several other equities research analysts have also weighed in on PRTK. HC Wainwright lowered Paratek Pharmaceuticals from a buy rating to […]
July 3, 2023
StockNews.com assumed coverage on shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Free Report) in a report published on Friday morning. The firm issued a hold rating on the specialty pharmaceutical company’s stock. Several other research firms have also commented on PRTK. BTIG Research reduced their price target on Paratek Pharmaceuticals from $24.00 to $5.00 in a […]